Science Brensocatib Shows Promise in Bronchiectasis Treatment with FDA Approval Brensocatib, marketed as Brinsupri, has received FDA approval for the treatment of bronchiectasis, marking a significant advancement in the management of this condition. In... Editorial7 hours ago